BMPR1A (Bone Morphogenetic Protein Receptor Type 1A), also known as ALK3 (Activin receptor-Like Kinase 3), is a serine/threonine kinase receptor for Bone Morphogenetic Protein (BMP) ligands. BMPR1A mediates BMP signaling in embryonic development, tissue homeostasis, and adult tissue repair. In the nervous system, BMPR1A regulates neural stem cell proliferation and differentiation, oligodendrocyte development, and neuroprotection. Dysregulation of BMPR1A signaling contributes to neurodevelopmental disorders, neurodegenerative diseases, and failed neural repair. [1]
BMPR1A represents a critical component of the BMP signaling pathway, one of the most important developmental signaling cascades in vertebrates. Its role in the central nervous system extends from early neural tube patterning to adult neural progenitor regulation and tissue repair.
| BMPR1A Receptor | |
|---|---|
| Gene Symbol | BMPR1A |
| Alternative Names | ALK3, BRK-1, SKK5 |
| Chromosomal Location | 10q22.3 |
| NCBI Gene ID | 652 |
| UniProt ID | P36894 |
| Protein Length | 532 amino acids |
| Molecular Weight | ~60 kDa |
| Protein Family | Serine/threonine kinase receptors |
| Ligands | BMP2, BMP4, BMP6, BMP7, BMP9, BMP10 |
| Expression | Neural stem cells, neurons, glia |
The BMPR1A gene spans approximately 44 kb on chromosome 10q22.3 and consists of 13 exons. The gene encodes a transmembrane receptor protein that is essential for BMP signal transduction. Multiple alternatively spliced variants have been identified with tissue-specific expression patterns.
BMPR1A contains distinct functional domains:
Extracellular Domain (~160 aa): Contains the ligand-binding region for BMP proteins. This domain includes:
Transmembrane Domain (~30 aa): Single α-helical transmembrane segment that anchors the receptor in the plasma membrane.
GS Domain (~60 aa): Glycine-serine rich region immediately intracellular to the transmembrane domain. This is the site where type II receptors phosphorylate BMPR1A.
Kinase Domain (~270 aa): Intracellular serine/threonine kinase domain with:
BMPR1A functions as a type I receptor in BMP signaling complexes:
BMPR1A mediates canonical BMP signaling:
BMPR1A also activates non-SMAD pathways:
During early neural development, BMPR1A signaling patterns the neural tube:
BMPR1A is critical for neural stem/progenitor cell biology: [1:1]
During neuronal development:
BMPR1A influences glial cell development:
BMPR1A plays a critical role in oligodendrocyte development: [2]
In multiple sclerosis and related demyelinating conditions:
BMPR1A manipulation shows promise for demyelinating diseases:
BMPR1A signaling is altered in Alzheimer's disease: [3]
In Parkinson's disease, BMPR1A signaling has complex roles: [4]
BMPR1A is involved in post-injury repair: [5]
In ALS:
| Cell Type | Expression | Function |
|---|---|---|
| Neural Stem Cells | High | Self-renewal, differentiation |
| Neurons | Moderate | Synaptic plasticity, survival |
| Astrocytes | High | Regulation of signaling |
| Oligodendrocyte Progenitors | High | Proliferation, differentiation |
| Mature Oligodendrocytes | Low | Myelin maintenance |
| Microglia | Moderate | Modulation of signaling |
Approaches to enhance BMPR1A signaling:
| Agent | Mechanism | Status | Notes |
|---|---|---|---|
| BMP4 protein | Direct agonist | Preclinical | Limited BBB penetration |
| BMP7 protein | Direct agonist | Clinical trials | Osteogenic, CNS effects |
| Small molecule agonists | Kinase activation | Discovery | Limited specificity |
| Gene therapy | Increased expression | Preclinical | Viral vector delivery |
For conditions where BMP signaling is excessive:
| Agent | Mechanism | Status | Notes |
|---|---|---|---|
| Noggin | BMP ligand sequestration | Preclinical | Protein therapeutic |
| Chordin | BMP ligand sequestration | Research | Limited availability |
| Dorsomorphin | Kinase inhibition | Research | Non-selective |
| LDN-193189 | Kinase inhibition | Preclinical | BMPR1A/ALK2 selective |
Liu A, et al. BMP signaling in neural stem and progenitor cells. Cell Stem Cell. 2009. ↩︎ ↩︎
Xiao L, et al. BMP/SMAD signaling in oligodendrocyte differentiation and demyelinating diseases. Journal of Molecular Neuroscience. 2019. ↩︎
Chen HL, et al. BMP signaling in Alzheimer's disease. Nat Rev Neurosci. 2017. ↩︎
Khalil H, et al. BMP signaling in Parkinson's disease. Cell Death Dis. 2019. ↩︎
Samtani R, et al. BMP signaling in neural repair after stroke. Stroke. 2020. ↩︎